Digital Summit: Accelerating FDA Diversity Action Plans
November 7, 2024 I 10am ET
In light of the updated draft guidance, we are bringing pharmaceutical companies, biotechs, and medical device companies from around the world the critical intel to ensure scientifically representative clinical studies are delivered.
- Hear leading experts’ thoughts on the updated guidance and how they tackle barriers to recruitment, retention, and inclusive research.
- Optimize your goal setting procedures with rigorous epidemiologically backed data science approaches.
- Deploy effective all-encompassing measures to engage underserved populations in clinical studies including community engagement, accessibility, burden-reduction, education, awareness and more.
- Learn how to utilize vendors and partners to improve representation.
Digital Sessions and Webinar
In our mission to progress industry alignment for diversity, equity, and inclusion in clinical studies we are expanding our focus of topics across 3 pillars of content to magnify the scope on how to improve health equity strategy.
Community Spotlight
Shines a light on communities that might be left out of the health equity picture, focuses on community engagement and implementing cultural competency and inclusive procedure in clinical research.
Disease Deep-Dive
Provides solutions to how we tailor health equity strategy to reflect epidemiology and furthers our understandings of how conditions interact with SDoH to be more specific with trial design and recruitment.
Health Equity Hotspot
Tackles critical barriers preventing participation in trials and shines a light on key stakeholders in the clinical trials ecosystem improve operations of DEI in engagement, recruitment and retention.
Upcoming Events
Health Equity Hotspot: How to Unlock the Potential of AI for Health Equity in Clinical Trials
December 2024
A range of innovative AI companies are now providing services that tackle barriers to trial participation for underserved patients. This session would draw on case studies of AI application as a mechanism to identify, recruit and/or retain diverse patient populations whilst discussing flaws of AI’s ability to undo structural barriers, preferably sharing a multi-faceted approach to community engagement through AI and boots on the ground.
Community Spotlight: Advancing Gender Identity and Sexuality Reporting in Clinical Research
February 2025
LGBTQIA+ representation in clinical trials has historically been poorly described in clinical research. This session describes how the industry can scientifically pinpoint disparities in SGM health outcomes and ensure protocols are designed to report data inclusively. Sharing how gender and sex can be effectively reported in clinical trials and how sexuality reporting leads to improved medical understanding and retention.
Disease Deep-Dive: How Culturally Competent Materials Can Accelerate Patient Recruitment in Oncology
April 2025
Discusses culturally competent clinical resources in terms of disability, sexual and gender identity, race and ethnicity as well as health literacy and medical understanding. Shares use cases of tailored culturally competent resources impact on clinical trial timelines. Reviews the use of digital vs paperback resources.
Health Equity Hotspot: Geomapping and Site Identification Through an Inclusive Research Lens
June 2025
Clinical research must reflect the epidemiology of disease as well as the population effected by the condition. This discussion reviews landscaping of clinical research for disease prevalence, engaged population demographics, trial sites, and culturally competent healthcare centers. This aims to share best practice during the site selection process for DEI strategy.
Community Spotlight: Breaking Down Participation of Asian Communities in Clinical Research
August 2025
Asian communities are underrepresented in clinical research despite high representation of professionals in the medical field. This discussion explores why Asian participation is lacking, what best practices for community engagement look like with Asian communities and how this can be integrated and applied to clinical trial recruitment strategy.
Health Equity Hotspot: How we Can Measure Progress for Racial Equity in Clinical Research
October 2025
Reviews our current ability to report race and ethnicity appropriately during the clinical trial process, explores returns on engagement vs actual recruited population in trials, how should we capture data so it reflects reality of a study and how can we develop a more culturally competent research protocol for people of colour.
Interested in Partnering?
The Health Equity in Clinical Trials Congress has cemented itself firmly as the meeting place for senior executives from the clinical trial ecosystem who are concerned with decreasing health inequities globally. The Congress focuses on creating action through an acute lense of progress; built upon partnerships and collaboration.
The agenda and audience are carefully curated each year to ensure we are bringing together the right people on the right topics, and creating change together. We work with a selection of strategic partners for the conference, delivering thought leadership, intimate networking and experiences and would love to explore how we can bring your strategies to life.
